Development of edible sorbent therapies to mitigate dietary exposures to per- and polyfluoroalkyl substances (PFAS)
开发可食用吸附剂疗法以减少膳食中全氟烷基物质和多氟烷基物质 (PFAS) 的暴露
基本信息
- 批准号:10590799
- 负责人:
- 金额:$ 8.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-10 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdsorptionAffinityAmendmentAnimalsBenignBindingBiochemistryBiological AssayBiological AvailabilityBirth WeightBloodBlood specimenBody WeightCell modelCellsChemicalsChemistryClinicalCommunitiesComplementComplexConsumptionDataDevelopmentDietDoseDrug Metabolic DetoxicationEmergency SituationEnvironmentEnvironmental PollutantsEventExposure toFemaleFire - disastersFloodsFoodFood ContaminationFrequenciesFrontline workerGastrointestinal tract structureGoalsHalf-LifeHealthHumanHuman MilkHurricaneIn VitroIndustrializationInfantInfertilityIngestionInhalation ExposureInterventionIntestinesKineticsLegal patentLicensingLow Birth Weight InfantMalignant neoplasm of testisMammalian CellMethodsMicrobeMicronutrientsModelingMontmorilloniteMycotoxinsNutrientOralOrganOrganismOutcomePartner in relationshipPathway interactionsPhasePoly-fluoroalkyl substancesPopulationPrevalenceProcessRattusReactionRenal carcinomaReportingResearchSafetySiteSoilStomachSurfaceSystemTestingTherapeuticThermodynamicsTimeToxic effectUrineVulnerable PopulationsWaterWorkclaycomparative efficacycomputational chemistrycomputer studiescontaminated drinking waterdata-driven modeldietarydosimetrydrinking waterefficacy validationenvironmental chemicalexposed human populationexposure routefirst responderimmunotoxicityin silicoin vitro Assayin vivoin vivo evaluationmalemolecular dynamicsnovelpregnantremediationsafety studyscreeningsimulationskillssubstance useuptake
项目摘要
ABSTRACT
Per- and polyfluoroalkyl substances (PFAS), also known as “forever chemicals”, are emerging contaminants of
concern due to their prevalence (in 99% of blood samples in the U.S.), long half-life, and adverse health effects
in humans. PFAS can be released, mobilized, and redistributed in the environment during emergencies such as
fires, industrial incidents, hurricanes, and flooding, thus enhancing human exposures and health effects. A major
challenge associated with these emergencies is protecting vulnerable populations including first responders,
frontline personnel, and communities at the impacted sites. There is a critical need for the development of
practical strategies to minimize dietary exposures to PFAS from drinking water and food, which account for 90%
of human exposures. Mitigation strategies using edible sorbents in the diet are safe for human consumption. The
long-term goal is to establish therapeutic sorbent interventions that will reduce oral and inhalation exposures to
complex environmental contaminants and microbes. The overall objective of this project is to develop edible,
multicomponent sorbents that will effectively reduce PFAS exposures from the diet. In this project, six
representative PFAS and their mixtures have been selected for complementary in vitro, in silico, and in vivo
studies. In Aim 1, multicomponent sorbents including processed and nutrient-amended clays will be derived from
materials that are naturally occurring, or generally recognized as safe. The in vitro adsorption studies will be
conducted in simulated gastrointestinal tract models to characterize surface interactions. The detoxification
efficacy of sorbent treatment will be validated in mammalian cell models and a living organism (Hydra vulgaris).
In Aim 2, molecular dynamics (MD) simulations, energetic analysis, minimalistic MD simulations, and data-driven
models will be used to study complex systems containing mixtures of PFAS and multicomponent sorbents.
Computational studies will validate sorption mechanisms and thermodynamics and integrate with Aim 1 for
sorbent selection and characterization. In Aim 3, the efficacy and safety of selected sorbents will be tested in
vivo. Male and pregnant female rats will be exposed to PFAS and sorbents will be included in the diet at varying
doses for 3 weeks. The 3 sorbents that most effectively reduce the PFAS bioavailability and show no interference
with nutrients will be included in a 6-month safety study. Parameters to be determined include 1) PFAS
bioavailability in blood, urine, and breast milk, 2) nutrient levels, 3) body weight, relative organ-to-body weight,
and infant birth weight, 4) feed conversion efficiency, and 5) clinical blood biochemistry. It is expected that
therapeutic sorbents developed in this research will be field-practical and easily delivered orally to neutralize
PFAS mixtures from dietary exposures to protect and treat vulnerable populations during emergencies.
摘要
全氟烷基和多氟烷基物质(PFAS),也被称为“永久化学品”,是新出现的污染物,
由于其患病率(在美国99%的血液样本中),半衰期长,对健康有不良影响
在人类身上。PFAS可以在紧急情况下释放,动员和重新分布在环境中,例如
火灾、工业事故、飓风和洪水,从而增加了人类接触和健康影响。一个主要
与这些紧急情况相关的挑战是保护弱势群体,包括第一反应者,
前线人员和受影响地区的社区。迫切需要发展
采取切实可行的策略,尽量减少从饮用水和食物中摄入PFAS,这占90%,
人体暴露。在饮食中使用可食用吸附剂的缓解策略对人类消费是安全的。的
长期目标是建立治疗吸附剂干预措施,减少口服和吸入暴露于
复杂的环境污染物和微生物该项目的总体目标是开发可食用,
多组分吸附剂,将有效地减少PFAS暴露的饮食。在这个项目中,6
已选择代表性PFAS及其混合物用于体外、计算机模拟和体内补充
问题研究在目标1中,多组分吸附剂,包括加工和营养改良的粘土,将来自于
天然存在的材料,或公认安全的材料。体外吸附研究将
在模拟胃肠道模型中进行,以表征表面相互作用。解毒
吸附剂处理的功效将在哺乳动物细胞模型和活生物体(水螅)中验证。
在目标2中,分子动力学(MD)模拟,能量分析,极简MD模拟和数据驱动
模型将被用来研究复杂的系统包含PFAS和多组分吸附剂的混合物。
计算研究将验证吸附机制和热力学,并与目标1相结合,
吸附剂选择和表征。在目标3中,将测试所选吸附剂的有效性和安全性,
vivo.雄性和妊娠雌性大鼠将暴露于PFAS,并将吸附剂以不同的剂量包含在饲料中。
剂量为3周。最有效降低PFAS生物利用度且无干扰的3种吸附剂
将被纳入为期6个月的安全性研究。待确定的参数包括:1)PFAS
血液、尿液和母乳中的生物利用度,2)营养水平,3)体重,相对器官与体重,
和婴儿出生体重,4)饲料转化率,和5)临床血液生化。预计在
在这项研究中开发的治疗吸附剂将是现场实用的,易于口服,以中和
在紧急情况下保护和治疗脆弱人群的膳食暴露PFAS混合物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Meichen Wang其他文献
Meichen Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于复合物结构预训练与元学习的药物靶点亲和力预测研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于深度学习的药物-靶点结合亲和力预测关键技术研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
WDR5蛋白全新口袋WAF特异性亲和小分子的构效关系和作用机制研究
- 批准号:QN25B020016
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
PRR佐剂调控APCs表面pMHC复合物稳定性
诱导高亲和力TCR T细胞克隆应答的机制
研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
超高亲和力、高亮度 Dimer 荧光 RNA 探针用于活细胞 RNA 单分子成像
- 批准号:24ZR1432500
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
亲和力引导联合Tsuji-Trost反应特异性标记胶质母细胞瘤TDO2的机理及应用研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
羟基磷灰石高亲和力多效复合肽在根尖周炎中的应用探讨和机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
高亲和力、稳定性、广谱性非甾体类抗炎药物纳米抗体的筛选及分
子识别机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
多级适配体的精准识别与亲和力调控用于三阴乳腺癌循环肿瘤细胞的捕获与抑制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
探索亲和力优化的 AXL-CAR-T 治疗甲状腺
未分化癌的安全性和有效性
- 批准号:TGY24H160109
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 8.74万 - 项目类别:
Continuing Grant